Literature DB >> 19360

Activation of botulinum toxins in the absence of nicking.

I Ohishi, G Sakaguchi.   

Abstract

The derivative toxins purified from cultures of proteolytic strains of Clostridium botulinum types A and F were found to have been only partially nicked but were fully activated. Trypsinization of C. botulinum type B derivative toxin at pH 6.0 resulted in simultaneous activation and nicking, whereas at pH 4.5, activation preceded nicking. The toxin was split by trypsin at pH 6.0 into two fragments with molecular weights of 112, ooo and 57,000. The toxin contained at least three trypsin-sensitive peptide bonds, one of which was more sensitive than the others at pH 6.0. These results indicate that activation of botulinum toxins by trypsin or endogenous protease (s) is not a direct result of nicking.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 19360      PMCID: PMC421135          DOI: 10.1128/iai.17.2.402-407.1977

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  13 in total

1.  Molecular construction of Clostridium botulinum type F progenitor toxin.

Authors:  I Ohishi; G Sakaguchi
Journal:  Appl Microbiol       Date:  1975-04

2.  Disulfide-toxicity relationship of botulinal toxin types A, E, and F.

Authors:  H Sugiyama; R Das Gupta; K H Yang
Journal:  Proc Soc Exp Biol Med       Date:  1973-07

3.  A common subunit structure in Clostridium botulinum type A, B and E toxins.

Authors:  B R DasGupta; H Sugiyama
Journal:  Biochem Biophys Res Commun       Date:  1972-07-11       Impact factor: 3.575

4.  Purification and some properties of Clostridium botulinum type-E toxin.

Authors:  M Kitamura; S Sakaguchi; G Sakaguchi
Journal:  Biochim Biophys Acta       Date:  1968-10-21

5.  Isolation and characterization of Clostridium botulinum type B toxin.

Authors:  W H Beers; E Reich
Journal:  J Biol Chem       Date:  1969-08-25       Impact factor: 5.157

6.  Rapid bioassay for Clostridium botulinum type-E toxins by intravenous injection into mice.

Authors:  G Sakaguchi; S Sakaguchi; H Kondo
Journal:  Jpn J Med Sci Biol       Date:  1968-12

7.  Statistical analysis of a rapid in vivo method for the titration of the toxin of Clostridium botulinum.

Authors:  D A Boroff; U Fleck
Journal:  J Bacteriol       Date:  1966-11       Impact factor: 3.490

8.  Purification and some properties of progenitor toxins of Clostridium botulinum type B.

Authors:  S Kozaki; S Sakaguchi; G Sakaguchi
Journal:  Infect Immun       Date:  1974-10       Impact factor: 3.441

9.  Molecular construction of Clostridium botulinum type A toxins.

Authors:  S Sugii; G Sakaguchi
Journal:  Infect Immun       Date:  1975-12       Impact factor: 3.441

10.  Purification of Clostridium botuliunum type F progenitor toxin.

Authors:  I Oishi; G Sakaguchi
Journal:  Appl Microbiol       Date:  1974-12
View more
  15 in total

1.  Comparison of extracellular and intracellular potency of botulinum neurotoxins.

Authors:  Fang Cai; Carrie B Adrion; James E Keller
Journal:  Infect Immun       Date:  2006-10       Impact factor: 3.441

2.  Clostridium botulinum type D toxin: purification, molecular structure, and some immunological properties.

Authors:  S Miyazaki; M Iwasaki; G Sakaguchi
Journal:  Infect Immun       Date:  1977-08       Impact factor: 3.441

3.  Circular dichroic and fluorescence spectroscopic study of the conformation of botulinum neurotoxin types A and E.

Authors:  A Datta; B R DasGupta
Journal:  Mol Cell Biochem       Date:  1988-02       Impact factor: 3.396

4.  Novel Native and Engineered Botulinum Neurotoxins.

Authors:  Lance Steward; Mitchell F Brin; Amy Brideau-Andersen
Journal:  Handb Exp Pharmacol       Date:  2021

5.  Binding of the two components of C2 toxin to epithelial cells and brush borders of mouse intestine.

Authors:  I Ohishi; M Miyake
Journal:  Infect Immun       Date:  1985-06       Impact factor: 3.441

Review 6.  Clostridium botulinum neurotoxin.

Authors:  H Sugiyama
Journal:  Microbiol Rev       Date:  1980-09

7.  Response of mouse intestinal loop to botulinum C2 toxin: enterotoxic activity induced by cooperation of nonlinked protein components.

Authors:  I Ohishi
Journal:  Infect Immun       Date:  1983-05       Impact factor: 3.441

8.  Purification and characterization of two components of botulinum C2 toxin.

Authors:  I Ohishi; M Iwasaki; G Sakaguchi
Journal:  Infect Immun       Date:  1980-12       Impact factor: 3.441

9.  Nature of intracellular type A botulinum neurotoxin.

Authors:  E P Krysinski; H Sugiyama
Journal:  Appl Environ Microbiol       Date:  1981-03       Impact factor: 4.792

10.  Evidence that botulinum C2 toxin has two dissimilar components.

Authors:  M Iwasaki; I Ohishi; G Sakaguchi
Journal:  Infect Immun       Date:  1980-08       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.